GENEVA, Oct. 27 -- ASTRAZENECA AB (SE-151-85Sodertalje) filed a patent application (PCT/IB2025/054061) for "SALTS AND POLYMORPHS OF CX3CR1 MODULATORS" on Apr 17, 2025. With publication no. WO/2025/219939, the details related to the patent application was published on Oct 23, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): LINDHAGEN, Marika (c/o AstraZeneca ABSE 151-85Sodertalje), BRINK, Mikael (c/o AstraZeneca ABSE151-85Sodertalje)
Abstract: The present disclosure provides meglumine salts of CX3CR1 modulators, polymorphs and pharmaceutical compositions thereof. Also disclosed are methods of...